BriaCell Therapeutics Corp. CEO William Williams' 2022 pay slips 2% to $811K

BriaCell Therapeutics Corp. reports 2022 executive compensation

By ExecPay News

Published: January 17, 2023

BriaCell Therapeutics Corp. reported fiscal year 2022 executive compensation information on January 17, 2023.
In 2022, four executives at BriaCell Therapeutics Corp. received on average a compensation package of $438K, a 33% increase compared to previous year.
Average pay of disclosed executives at BriaCell Therapeutics Corp.
William V. Williams, Chief Executive Officer, received $811K in total, which decreased by 2% compared to 2021. 69% of Williams' compensation, or $561K, was in salary. Williams also received $150K in non-equity incentive plan and $100K in option awards.
Giuseppe Del Priore, Chief Medical Officer, received a compensation package of $416K. 52% of the compensation package, or $216K, was in option awards.
Miguel A. Lopez-Lago, Chief Scientific Officer, earned $269K in 2022, a 558% increase compared to previous year.
Gadi Levin, Chief Financial Officer, received $256K in 2022, which increases by 124% compared to 2021.
BriaCell Therapeutics Corp.'s fiscal year ends on July 31.

Related executives

William Williams

BriaCell Therapeutics Corp.

Chief Executive Officer

Gadi Levin

BriaCell Therapeutics Corp.

Chief Financial Officer

Giuseppe Del Priore

BriaCell Therapeutics Corp.

Chief Medical Officer

Miguel Lopez-Lago

BriaCell Therapeutics Corp.

Chief Scientific Officer

You may also like

Source: SEC filing on January 17, 2023.